Legionnaires disease with bacteremic coinfection

Clinical Infectious Diseases

Volumn 35, Issue 5, 2002, Pages 533-539

  Tan, Michael J ^a   Tan, James S ^a   File, Thomas M ^a  

^a SUMMA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BACTERIUM ANTIBODY; BETA LACTAM ANTIBIOTIC; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; MEROPENEM; SULTAMICILLIN; TIMENTIN;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; CLINICAL ARTICLE; COMORBIDITY; DISEASE PREDISPOSITION; ENDEMIC DISEASE; ENTEROBACTER CLOACAE; FEMALE; HUMAN; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; MALE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PYOGENES; URINALYSIS;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; MALE; MIDDLE AGED; PATIENT SELECTION; PNEUMONIA; RETROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE;

EID: 0036721446     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/341771     Document Type: Article

References (31)

1. The effects of influenza on host defenses
2. Coinfection is common in measles-associated pneumonia
3. Multiple pathogens in adult patients admitted with community-acquired pneumonia: A one year prospective study of 346 consecutive patients
4. Atypical pneumonia in the Nordic countries: Aetiology and clinical results of a trial comparing fleroxacin and doxycycline - Nordic Atypical Pneumonia Study Group
5. Legionnaires' disease in patients with associated serious disease
6. Legionnaires disease: Description of an epidemic of pneumonia
7. Management of Legionella pneumonia
8. Risk factors for domestic acquisition of Legionnaires disease
9. Interaction of Legionella pneumophila with protozoa provides lessons
10. Incidence of community-acquired pneumonia requiring hospitalization: Results of a population-based active surveillance study in Ohio
11. Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society
12. Surveillance for Legionnaires' disease: Risk factors for morbidity and mortality
13. Clinical features of Legionnaires disease
14. Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia
15. The radiologic manifestations of legionnaires' disease
16. Antimicrobial treatment failures in patients with community-acquired pneumonia
17. Can Legionnaires disease be diagnosed by clinical criteria?
18. Guidelines for the management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, antimicrobial therapy, and prevention
19. Practice guidelines for the management of community-acquired pneumonia in adults
20. Concurrent community-acquired pneumonia with Legionella pneumophila and Streptococcus pneumoniae
21. Aetiology of community-acquired pneumonia: A prospective study among adults requiring admission to hospital
22. Prospective study of pneumonia: Unexpected incidence of legionellosis
23. Legionnaires' disease association with Mycoplasma pneumonia and disseminated intravascular coagulation
24. Simultaneous infection with Legionella pneumophila and Pittsburgh pneumonia agent
25. Ambulatory patients with community-acquired pneumonia: The frequency of a typical agents and clinical course
26. Community-acquired pneumonia: Impact of immune status
27. Bacterial pneumonia as a superinfection in young adults with measles
28. The influence of bacterial superinfection on the clinical course of influenza: Studies from the influenza epidemics in Stockholm during the winters 1969-70 and 1971-72
29. Severe pneumococcal pneumonia in previously healthy children: The role of preceding influenza infection
30. Effect of bacterial products on human ciliary function in vitro
31. Legionella and community-acquired pneumonia: A review of current diagnostic tests from a clinician's viewpoint